Ignite Creation Date:
2025-12-24 @ 1:39 PM
Ignite Modification Date:
2026-04-13 @ 11:54 PM
Study NCT ID:
NCT00496795
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-06-29
First Post:
2007-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer
Sponsor:
University of Bergen
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Ethics committee 079.06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |